In 2017, Roy et al. (2017) were the first to suggest that RARRES1 plays a role in regulating angiogenesis by demonstrating its inhibitory effect on tube formation in HUVECs in the context of prostate cancer. This evidence concerns the gene RARRES1 and Familial prostate cancer.